This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.95, is for the delivery of Oxymorphone HCL ER 20 mg tablets. The contract has an ultimate completion date of April 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxymorphone HCL ER Tablets 20mg, a prescription pain medication. The contract has a firm fixed price, a ceiling value of $8,605.76, and a period of performance through April 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.32 firm-fixed-price contract is for the delivery of Oxymorphone HCL ER Tabs 40mg, a pain management medication. The contract has an ultimate completion date of June 16, 2025 and is not set aside for any special business categories. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,107.93 firm fixed price contract is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of May 6, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $5,509.62, is for the delivery of oxymorphone hydrochloride extended-release tablets with a 40mg strength. The contract is a firm-fixed-price delivery order with a performance period ending on January 2, 2024. There is no set-aside designation for this award....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Oxymorphone HCL ER 20 MG tablets, with a ceiling value of $2,836.52 and a completion date of October 26, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Oxymorphone HCL ER Tablets (20mg) to support U.S. military and government medical programs. The contract has a ceiling value of $7,727.86 and runs through October 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 15mg oxymorphone hydrochloride extended-release tablets. The order, valued at $3,479.38, has a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.03 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER 10 mg tablets. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...